| A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3. | A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3.
Xiao Q, Wang L, Wang J, Wang M, Wang DW, Ding H., Free PMC Article | 09/24/2024 |
| Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes. | Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.
Naber A, Demus D, Slieker RC, Nicolardi S, Beulens JWJ, Elders PJM, Lieverse AG, Sijbrands EJG, 't Hart LM, Wuhrer M, van Hoek M., Free PMC Article | 06/10/2024 |
| Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance. | Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.
Packard CJ, Pirillo A, Tsimikas S, Ference BA, Catapano AL., Free PMC Article | 02/22/2024 |
| Apolipoprotein C3 (ApoC3) facilitates NLRP3 mediated pyroptosis of macrophages through mitochondrial damage by accelerating of the interaction between SCIMP and SYK pathway in acute lung injury. | Apolipoprotein C3 (ApoC3) facilitates NLRP3 mediated pyroptosis of macrophages through mitochondrial damage by accelerating of the interaction between SCIMP and SYK pathway in acute lung injury.
Pu Z, Wang W, Xie H, Wang W. | 02/13/2024 |
| [The role of apolipoprotein C3 in the regulation of nonalcoholic fatty liver disease, glucose and lipid metabolism, and islet beta cell function]. | [The role of apolipoprotein C3 in the regulation of nonalcoholic fatty liver disease, glucose and lipid metabolism, and islet β cell function].
Yan S, Ding ZY, Gao Y, Mao WJ, Cheng XY. | 01/30/2024 |
| Apolipoprotein C3: form begets function. | Apolipoprotein C3: form begets function.
Bornfeldt KE., Free PMC Article | 01/30/2024 |
| SP1 transcriptionally upregulates the expression of APOC3 in KGN cells to promote disease progression by regulating TLR2/NF-kappaB signalling pathway. | SP1 transcriptionally upregulates the expression of APOC3 in KGN cells to promote disease progression by regulating TLR2/NF-κB signalling pathway.
Qi N, Wen L, Li S, Li J, Feng C. | 11/1/2023 |
| [Association Between Apolipoprotein C-3 Sst Polymorphism and Serum Lipids in Patients With Gestational Diabetes Mellitus]. | [Association Between Apolipoprotein C-3 SstⅠ Polymorphism and Serum Lipids in Patients With Gestational Diabetes Mellitus].
Tang F, Bai H, Guan L, Liu X, Fan P, Zhou M, Wu Y, Liu S, Wang Y, Li D., Free PMC Article | 10/28/2023 |
| Role of APOC3 3238C/G polymorphism in HIV-associated neurocognitive disorder. | Role of APOC3 3238C/G polymorphism in HIV-associated neurocognitive disorder.
Singh H, Dhotre K, Shyamveer, Namdev G, Mahajan SD, Parvez MK, Al-Dosari MS. | 05/17/2023 |
| APOC3 and ABCA1 variants in unusual combined hypolipidaemia showing premature peripheral vascular disease. | APOC3 and ABCA1 variants in unusual combined hypolipidaemia showing premature peripheral vascular disease.
Pos Z, Khedr M, Radvanszky J, Penesova A, Hekel R, Szemes T, Ranganath LR, Zatkova A. | 04/14/2023 |
| Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels. | Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels.
Taşkin E, Bağci H, Turan MK., Free PMC Article | 03/22/2023 |
| Apolipoprotein C3 is negatively associated with estrogen and mediates the protective effect of estrogen on hypertriglyceridemia in obese adults. | Apolipoprotein C3 is negatively associated with estrogen and mediates the protective effect of estrogen on hypertriglyceridemia in obese adults.
Li J, Sun H, Wang Y, Liu J, Wang G., Free PMC Article | 03/2/2023 |
| APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism. | APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.
Giammanco A, Spina R, Cefalù AB, Averna M., Free PMC Article | 02/26/2023 |
| Guanidinylated Apolipoprotein C3 (ApoC3) Associates with Kidney and Vascular Injury. | Guanidinylated Apolipoprotein C3 (ApoC3) Associates with Kidney and Vascular Injury.
Schunk SJ, Hermann J, Sarakpi T, Triem S, Lellig M, Hahm E, Zewinger S, Schmit D, Becker E, Möllmann J, Lehrke M, Kramann R, Boor P, Lipp P, Laufs U, März W, Reiser J, Jankowski J, Fliser D, Speer T, Jankowski V., Free PMC Article | 02/11/2023 |
| Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations. | Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.
Taskinen MR, Björnson E, Matikainen N, Söderlund S, Rämö J, Ainola MM, Hakkarainen A, Sihlbom C, Thorsell A, Andersson L, Bergh PO, Henricsson M, Romeo S, Adiels M, Ripatti S, Laakso M, Packard CJ, Borén J., Free PMC Article | 01/11/2023 |
| ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC. | ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC.
Wang J, Man Q, Zhong N, Wang H, Zhang C, Li S, Bu L, Liu B., Free PMC Article | 11/19/2022 |
| Apolipoprotein C3 and necrotic core volume are correlated but also associated with future cardiovascular events. | Apolipoprotein C3 and necrotic core volume are correlated but also associated with future cardiovascular events.
Ohwada T, Sakamoto T, Suzuki S, Sugawara Y, Sakamoto K, Ikeda A, Haga F, Sato T, Nakazato K, Takeishi Y, Watanabe K., Free PMC Article | 09/3/2022 |
| Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease. | Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.
Hernández-Camba A, Carrillo-Palau M, Ramos L, de Armas-Rillo L, Vela M, Arranz L, González-Gay MÁ, Ferraz-Amaro I., Free PMC Article | 07/2/2022 |
| Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis. | Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis.
Martín-González C, Martín-Folgueras T, Quevedo-Abeledo JC, de Vera-González A, González-Delgado A, de Armas-Rillo L, González-Gay MÁ, Ferraz-Amaro I., Free PMC Article | 06/18/2022 |
| Apolipoprotein C-III in patients with systemic lupus erythematosus. | Apolipoprotein C-III in patients with systemic lupus erythematosus.
Martín-González C, Ferrer-Moure C, Carlos Quevedo-Abeledo J, de Vera-González A, González-Delgado A, Sánchez-Martín J, González-Gay MÁ, Ferraz-Amaro I., Free PMC Article | 05/14/2022 |
| The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis. | The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis.
de Armas-Rillo L, Quevedo-Abeledo JC, Hernández-Hernández V, de Vera-González A, González-Delgado A, García-Dopico JA, González-Gay MÁ, Ferraz-Amaro I., Free PMC Article | 05/14/2022 |
| J-shaped association between circulating apoC-III and cardiovascular mortality. | J-shaped association between circulating apoC-III and cardiovascular mortality.
Silbernagel G, Scharnagl H, Kleber ME, Hoffmann MM, Delgado GE, Stojakovic T, Gary T, Zeng L, Ritsch A, Zewinger S, Speer T, Schunkert H, Landmesser U, März W, Grammer TB. | 04/23/2022 |
| Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. | Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, Ballantyne CM, Hoogeveen RC., Free PMC Article | 04/23/2022 |
| Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria. | Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria.
Jansson Sigfrids F, Stechemesser L, Dahlström EH, Forsblom CM, Harjutsalo V, Weitgasser R, Taskinen MR, Groop PH, FinnDiane Study Group., Free PMC Article | 04/2/2022 |
| Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects. | Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects.
Rodríguez M, Rehues P, Iranzo V, Mora J, Balsells C, Guardiola M, Ribalta J. | 03/5/2022 |